FibroBiologics, Inc.
FBLG
$0.94
$0.011.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.00M | -3.24M | -5.78M | -4.66M | -4.97M |
| Total Depreciation and Amortization | 237.00K | 234.00K | 231.00K | 206.00K | 161.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 625.00K | -- |
| Total Other Non-Cash Items | 640.00K | 1.18M | 1.52M | 322.00K | 1.09M |
| Change in Net Operating Assets | -241.00K | -1.34M | 58.00K | -479.00K | -1.56M |
| Cash from Operations | -4.36M | -3.16M | -3.97M | -3.98M | -5.28M |
| Capital Expenditure | -- | 0.00 | -6.00K | -213.00K | -43.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | -6.00K | -213.00K | -43.00K |
| Total Debt Issued | 327.00K | 0.00 | 0.00 | 4.38M | -- |
| Total Debt Repaid | -81.00K | -3.40M | -- | -- | -- |
| Issuance of Common Stock | 706.00K | 6.59M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 952.00K | 3.19M | 0.00 | 4.38M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.41M | 27.00K | -3.98M | 178.00K | -5.32M |